(PRESS RELEASE) BERLIN, 19-Feb-2026 — / EuropaWire / — Germany, Latvia and Lithuania are moving forward with plans to develop the Baltic-German PowerLink, a cross-border electricity transmission ...
Novartis announced positive Phase III results from the RemIND trial showing that the oral BTK inhibitor remibrutinib achieved significantly higher complete response rates than placebo in three major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results